Table 3.
Logistic regression | Overall correct percentage of prediction* | Receiver operating curve analysis | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Model acceptance | Goodness of fit | OR and adjusted OR‡ | |||||||||||||
Predictors | Unit increment | Final −2 log likelihood | P value of OTMC | Nagelkerke r2 | Hosmer–Lemeshow test | Wald test | Exp (B) | Lower 95% CI | Upper 95% CI | Area under curves | P value† | Cut value* | Final model status | ||
Tachycardia | AUCnef0→∞ | 1 μg l−1 h | 26.390 | 0.128 | 0.250 | 0.867 | 0.049 | 1.001‡ | 1.000 | 1.002 | 80% | 0.788 | 0.019 | 3280 μg l−1 h | |
Cmaxnef | 1 μg l−1 | 24.338 | 0.05 | 0.330 | 0.770 | 0.025 | 1.010‡ | 1.003 | 1.018 | 83% | 0.887 | 0.002 | 389 μg l−1 | Appropriate | |
50 μg l−1 | 0.025 | 1.580‡ | 1.060 | 2.355 | Appropriate | ||||||||||
RCmaxnef | 1 μg l−1 h−1 | 24.058 | 0.046 | 0.341 | 0.755 | 0.023 | 1.005‡ | 1.001 | 1.009 | 83% | 0.892 | 0.001 | 764 μg l−1 h−1 | Appropriate | |
50 μg l−1 h−1 | 0.023 | 1.261‡ | 1.033 | 1.538 | Appropriate | ||||||||||
PONV | AUCnef0→∞ | 1 μg l−1 h | 28.742 | 0.079 | 0.328 | 0.550 | 0.021 | 1.002‡ | 1.000 | 1.003 | 82.4% | 0.726 | 0.056 | 3280 μg l−1 h | |
Cmaxnef | 1 μg l−1 | 23.335 | 0.008 | 0.501 | 0.829 | 0.012 | 1.014‡ | 1.003 | 1.026 | 85.3% | 0.774 | 0.021 | 437.44 μg l−1 | Appropriate | |
50 μg l−1 | 0.012 | 2.053‡ | 1.169 | 3.605 | Appropriate | ||||||||||
RCmaxnef | 1 μg l−1 h−1 | 23.482 | 0.009 | 0.497 | 0.882 | 0.012 | 1.007‡ | 1.002 | 1.012 | 85.3% | 0.744 | 0.21 | 859 μg l−1 h−1 | Appropriate | |
50 μg l−1 h−1 | 0.012 | 1.416‡ | 1.078 | 1.859 | Appropriate | ||||||||||
Morphine requirement | AUCnef0→∞ | 1 μg l−1 h | 41.468 | 0.006 | 0.253 | 0.350 | 0.023 | 0.988 | 0.987 | 1.000 | 68% | 0.745 | 0.013 | 947 μg l−1 h | Appropriate |
Cmaxnef | 1 μg l−1 | 41.797 | 0.007 | 0.243 | 0.349 | 0.048 | 0.988 | 0.977 | 1.000 | 68% | 0.724 | 0.024 | 79 μg l−1 | Appropriate | |
RCmaxnef | 1 μg l−1 h−1 | 41.567 | 0.006 | 0.250 | 0.353 | 0.047 | 0.994 | 0.988 | 1.000 | 68% | 0.730 | 0.020 | 154 μg l−1 h−1 | Appropriate |
Abbreviations are as follows: AUCnef0→∞, Area Under Curve of time course of nefopam plasma concentration; Cmaxnef, nefopam plasma maximum concentration; CI, confidence interval; OR, odds ratio; OTMC, omnibus test of model coefficients; PONV, postoperative nausea and vomiting; RCmax, rate of increase of plasma concentration.
The cut value corresponds to the predicted probability of the model higher than 0.60 for tachycardia, 0.80 for PONV and 0.50 for morphine requirement.
Null hypothesis/true area = 0.5.
Adjusted for confounding covariates (see the results of the pharmacodynamics assessment); AUCnef0→∞, Cmaxnef and RCmaxnef were ranged, respectively, within 382.5–3620 μg l−1 h, 19.2–512.8 μg l−1 and 37.7–1037 μg l−1 h−1.